The investigators aim to investigate the efficacy and tolerability of a hybrid non-ablative/ablative laser for acne scarring in skin of color.
Healthy males and females, ≥ 18 years of age at time of informed consent, seeking treatment for acne scarring
Subject must voluntarily sign and date an IRB approved informed consent form
Subjects with diagnosis of acne scarring recorded over the past 6 months
Able to read, understand and voluntarily provide written informed consent.
Subjects does not have the capacity to consent to the study
subject underwent any acne scar treatments in the past 6 months prior to enrollment in the study
Subject has active papulopustular or cystic acne within the past 6 months.
Any history of keloidal scarring.
Single group
Sciton Halo
DeviceLaser treatment
Change from baseline acne scar severity
2 Independent unbiased blinded dermatologists will rate before and after treatment images using Global Scale for Acne Scarring. This scale is rated on a scale of 0 to 5. 0 is the least severe, and 5 is the most severe.
Change from baseline acne scar severity
2 Independent unbiased blinded dermatologists will rate before and after treatment images using Global Scale for Acne Scarring. This scale is rated on a scale of 0 to 5. 0 is the least severe, and 5 is the most severe.
Change from baseline acne scar severity
2 Independent unbiased blinded dermatologists will rate before and after treatment images using Global Scale for Acne Scarring. This scale is rated on a scale of 0 to 5. 0 is the least severe, and 5 is the most severe.
Baseline Patient Satisfaction
Patient Satisfaction Questionnaire. Questions are on a scale of -3 to 3, with -3 meaning the condition greatly decreased, and 3 meaning the condition greatly increased.
Click on the lead sponsor to view all of their trials.
